Robust Data Set of Nine Trials over Four Years
According to independent trials by the North Dakota State University, Rovral Flo is a good choice for protection from sclerotinia. With performance comparable to a market standard, Rovral Flo will maximize returns under heavy sclerotinia pressure situations and minimize costs when that does not materialize.